- Home
- VLYPP vs RVMDW Comparison
VLYPP vs RVMDW Comparison
Compare VLYPP & RVMDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLYPP
- RVMDW
- Stock Information
- Founded
- VLYPP N/A
- RVMDW 2014
- Country
- VLYPP United States
- RVMDW United States
- Employees
- VLYPP 3749
- RVMDW N/A
- Industry
- VLYPP Major Banks
- RVMDW
- Sector
- VLYPP Finance
- RVMDW
- Exchange
- VLYPP Nasdaq
- RVMDW Nasdaq
- Market Cap
- VLYPP N/A
- RVMDW N/A
- IPO Year
- VLYPP N/A
- RVMDW N/A
- Fundamental
- Price
- VLYPP $25.22
- RVMDW $0.18
- Analyst Decision
- VLYPP
- RVMDW
- Analyst Count
- VLYPP 0
- RVMDW 0
- Target Price
- VLYPP N/A
- RVMDW N/A
- AVG Volume (30 Days)
- VLYPP N/A
- RVMDW 15.6K
- Earning Date
- VLYPP N/A
- RVMDW 02-26-2025
- Dividend Yield
- VLYPP N/A
- RVMDW N/A
- EPS Growth
- VLYPP N/A
- RVMDW N/A
- EPS
- VLYPP N/A
- RVMDW N/A
- Revenue
- VLYPP N/A
- RVMDW $742,000.00
- Revenue This Year
- VLYPP N/A
- RVMDW N/A
- Revenue Next Year
- VLYPP N/A
- RVMDW N/A
- P/E Ratio
- VLYPP N/A
- RVMDW N/A
- Revenue Growth
- VLYPP N/A
- RVMDW N/A
- 52 Week Low
- VLYPP N/A
- RVMDW $0.10
- 52 Week High
- VLYPP N/A
- RVMDW $0.12
- Technical
- Relative Strength Index (RSI)
- VLYPP 53.72
- RVMDW N/A
- Support Level
- VLYPP $24.91
- RVMDW N/A
- Resistance Level
- VLYPP $25.49
- RVMDW N/A
- Average True Range (ATR)
- VLYPP 0.17
- RVMDW 0.00
- MACD
- VLYPP -0.00
- RVMDW 0.00
- Stochastic Oscillator
- VLYPP 52.54
- RVMDW 0.00
About VLYPP Valley National Bancorp 6.25% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series A
Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.
About RVMDW Revolution Medicines Inc. Warrant
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.